Recent advances in diagnostic testing and therapeutic management have greatly improved our ability to deliver care to patients with disorders of hemostasis. Many individuals remain inadequately evaluated or treated, however, for a variety of reasons, including incomplete or incorrect diagnostic testing, inadequate management strategies, and patient lack of access to the healthcare system. We implemented the Duke Comprehensive Hemostasis & Thrombosis Center to integrate existing areas of clinical expertise in the Duke University Health System into a coordinated service. The Center also provides access to clinical research 3rotocols, emphasizes patient education, and has provided the groundwork for developing a training program for healthcare providers interested in disorders of hemostasis. The following Aims will enhance the activity and mission of the Duke Hemostasis & Thrombosis Center. (1) Determine the efficacy of integrated multi-disciplinary care and prevention services for persons with hemophilia, other hereditary bleeding disorders including women with bleeding disorders, and thrombophilia to reduce morbidity and mortality associated with bleeding and clotting diseases. Monitoring strategies will focus on clinical outcomes, patient access, and patient satisfaction. (2) Assess unmet needs for service delivery and identify outreach strategies designed to improve access to care. Unmet needs will be identified at a local level as well as at regional and national levels. (3) Develop effective messages aimed at disease management and prevention. Internet-based as well as paper-based educational messages will be developed to promote patient awareness and education. (4) Foster the development of training programs to enhance provider skills for the delivery of care to persons with disorders of hemostasis. We will use the information obtained through these Aims to enhance the quality of the clinical services that are provided through the Duke Hemostasis & Thrombosis Center, as well as developing exceptional training opportunities for healthcare providers, clinical researchers, and basic investigators.

Agency
National Institute of Health (NIH)
Institute
Centers for Disease Control and Prevention (NCBDD)
Type
Research Demonstration--Cooperative Agreements (U18)
Project #
5U18DD000014-02
Application #
7075385
Study Section
Special Emphasis Panel (ZDD1-SRC (99))
Program Officer
Irannejad, Nassi
Project Start
2004-07-01
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
2
Fiscal Year
2005
Total Cost
$250,000
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Faiz, Ambarina S; Khan, Imran; Beckman, Michele G et al. (2015) Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism. Thromb Res 136:535-41
Lewis, Deborah A; Suchindran, Sunil; Beckman, Michele G et al. (2015) Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism. Thromb Res 135:659-65
Hester, Willie; Fry, Caitlyn; Gonzalez, Daniel et al. (2014) Thromboprophylaxis with fondaparinux in high-risk postoperative patients with renal insufficiency. Thromb Res 133:629-33
Bennett, Charles L; Jacob, Sony; Dunn, Brianne L et al. (2013) Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR). Br J Haematol 161:896-8
Limmer, Jane S; Grotegut, Chad A; Thames, Elizabeth et al. (2013) Postpartum wound and bleeding complications in women who received peripartum anticoagulation. Thromb Res 132:e19-23
Landi, Daniel; Beckman, Michele G; Shah, Nirmish R et al. (2013) Characteristics of abdominal vein thrombosis in children and adults. Thromb Haemost 109:625-32
Ortel, Thomas L (2012) Perioperative management of patients on chronic antithrombotic therapy. Hematology Am Soc Hematol Educ Program 2012:529-35
Ortel, Thomas L (2012) Perioperative management of patients on chronic antithrombotic therapy. Blood 120:4699-705
Ortel, Thomas L (2012) Antiphospholipid syndrome: laboratory testing and diagnostic strategies. Am J Hematol 87 Suppl 1:S75-81
Ortel, Thomas L (2009) Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation. Hematology Am Soc Hematol Educ Program :225-32

Showing the most recent 10 out of 17 publications